FIGURE 1.
Large prospective randomized trials of sodium‐glucose cotransporter 2 inhibitors in patients with heart failure, type 2 DM and CKD according to the major enrolment criteria. CKD, chronic kidney disease; DM, diabetes mellitus.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.